menu
more_vert
Home / Reports / Active Pharmaceutical Ingredient Market

Global Active Pharmaceutical Ingredient Market By Type (Synthetic API, and Biotech API), By Application (Non-steroidal Anti-inflammatory Drugs (NSAIDs), Oncology Drugs, and Others), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2019–2028

  • account_circleAbout Me
    • 22857
    • Dec 2018
    • $2,495.00
    • $3,795.00
    • $4,995.00
    Buy Now

    The report on Active Pharmaceutical Ingredient Market offers in-depth analysis on market trends, drivers, restraints, opportunities etc. Along with qualitative information, this report include the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. for the forecast years. The global active pharmaceutical ingredient market is segmented on the basis of type, application and geography.

    The worldwide market for Active Pharmaceutical Ingredient Market is expected to grow at a CAGR of roughly 6.6% over the next ten years and will reach US$ 333.9 Mn in 2028, from US$ 176.4 Mn in 2018, according to a new Market.us (Prudour Research) study.

    Active Pharmaceutical Ingredient Market Scope:

    By type, the market is segmented into Synthetic API and Biotech API. By application, the market is divided into Non-steroidal Anti-inflammatory Drugs (NSAIDs) , Oncology Drugs
    , Anti-diabetic Drugs , Cardiovascular Drugs, Central Nervous System Drugs (CNS Drugs)
    and Musculoskeletal Drugs. Based on geography, market is analyzed across North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. Major players profiled in the report include Teva, Novartis, Pfizer, Johnson & Johnson, Mylan, North China Pharmaceutical Group, Dr. Reddys Laboratories, Roche, Aurobindo pharma, Sun Pharmaceutical Industries, Boehringer Ingelheim GmbH, Bayer, BASF, DSM, Zhejiang zedicine, Biocon, Johnson Matthey, Hisun Pharmacy, Cambrex and Shandong Xinhua Pharmaceutical.

    trending_up Total Revenue in 2018

    $ 176.4 Mn

    trending_up Market CAGR of the Next Ten Years

    6.6 %

    no_encryption Market Value (US$ Mn), Share (%) and Growth Rate (%) Comparison 2012-2028
    Purchase this report or a membership to unlock the market value (US$ Mn), share (%) and growth rate (%) comparison for this industry.
    • By Type
    • By Region
    • By Application
    no_encryption Leading Companies Financial Highlights
    Purchase this report or a membership to unlock the leading companies financial highlights for this industry.

    trending_up Market Revenue of the Next Ten Years

    $ 333.9 Mn

    Key Market Segments:

    Type

    • Synthetic API
    • Biotech API

    Application

    • Non-steroidal Anti-inflammatory Drugs (NSAIDs)
    • Oncology Drugs
    • Anti-diabetic Drugs
    • Cardiovascular Drugs
    • Central Nervous System Drugs (CNS Drugs)
    • Musculoskeletal Drugs

    Key Market Players included in the report:

    • Teva
    • Novartis
    • Pfizer
    • Johnson & Johnson
    • Mylan
    • North China Pharmaceutical Group
    • Dr. Reddys Laboratories
    • Roche
    • Aurobindo pharma
    • Sun Pharmaceutical Industries
    • Boehringer Ingelheim GmbH
    • Bayer
    • BASF
    • DSM
    • Zhejiang Medicine
    • Biocon
    • Johnson Matthey
    • Hisun Pharmacy
    • Cambrex
    • Shandong Xinhua Pharmaceutical

    Reasons to Get this Report:

    In an insight outlook, this research report has dedicated to several quantities of analysis - industry research (global industry trends) and Active Pharmaceutical Ingredient Market share analysis of high players, along with company profiles and which collectively include about the fundamental opinions regarding the market landscape. Emerging and high-growth sections of Active Pharmaceutical Ingredient Market, high-growth regions, and market drivers, restraints and also market chances.

    The analysis covers Active Pharmaceutical Ingredient Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Active Pharmaceutical Ingredient Market across sections such as also application and representatives.

    Additionally, the analysis also has a comprehensive review of the crucial players on the Active Pharmaceutical Ingredient Market together side their company profiles, SWOT analysis, latest advancements and business plans.

    The analysis objectives of the report are:

    • To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers and industry-specific challenges and risks).
    • To know the Active Pharmaceutical Ingredient Market by pinpointing its many subsegments.
    • To profile the important players and analyze their growth plans.
    • To endeavor the amount and value of Active Pharmaceutical Ingredient sub-markets, depending on key regions (various vital states).
    • To analyze Active Pharmaceutical Ingredient Market concerning growth trends, prospects and also their participation in the entire sector.
    • To examine and study the Active Pharmaceutical Ingredient Market size (volume & value) from the company, essential regions/countries, products and application, background information from 2012 to 2018 and also prediction to 2028.
    • Primary worldwide Active Pharmaceutical Ingredient Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
    • To examine competitive progress such as expansions, arrangements, new product launches and acquisitions on the market.

    For the Active Pharmaceutical Ingredient Market research study, the following years have been considered to estimate the market size:

    ParticularScope
    Region

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East and Africa

    Historic Year2012 to 2017
    Estimated Year2018
    Forecast Year2019 to 2028

    Active Pharmaceutical Ingredient Market

    add_shopping_cartBuy Now get_appDownload Sample
    keyboard_arrow_up
  • account_circleAbout Me
    • 22857
    • Dec 2018
    • $2,495.00
    • $3,795.00
    • $4,995.00
    Buy Now
    • 1. Active Pharmaceutical Ingredient Market Introduction
      • 1.1. Definition
      • 1.2. Taxonomy
      • 1.3. Research Scope
    • 2. Executive Summary
      • 2.1. Key Findings by Major Segments
      • 2.2. Top strategies by Major Players
    • 3. Global Active Pharmaceutical Ingredient Market Overview
      • 3.1. Active Pharmaceutical Ingredient Market Dynamics
        • 3.1.1. Drivers
        • 3.1.2. Opportunities
        • 3.1.3. Restraints
        • 3.1.4. Challenges
      • 3.2. PESTLE Analysis
      • 3.3. Opportunity Map Analysis
      • 3.4. PORTER'S Five Forces Analysis
      • 3.5. Market Competition Scenario Analysis
      • 3.6. Product Life Cycle Analysis
      • 3.7. Opportunity Orbits
      • 3.8. Manufacturer Intensity Map
    • 4. Global Active Pharmaceutical Ingredient Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
      • 4.1. Global Active Pharmaceutical Ingredient Market Analysis by Type: Introduction
      • 4.2. Market Size and Forecast by Region
      • 4.3. Synthetic API
      • 4.4. Biotech API
    • 5. Global Active Pharmaceutical Ingredient Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
      • 5.1. Global Active Pharmaceutical Ingredient Market Analysis by Application: Introduction
      • 5.2. Market Size and Forecast by Region
      • 5.3. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
      • 5.4. Oncology Drugs
      • 5.5. Anti-diabetic Drugs
      • 5.6. Cardiovascular Drugs
      • 5.7. Central Nervous System Drugs (CNS Drugs)
      • 5.8. Musculoskeletal Drugs
    • 6. Global Active Pharmaceutical Ingredient Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
      • 6.1. North America
        • 6.1.1. North America Active Pharmaceutical Ingredient Market: Regional Trend Analysis
          • 6.1.1.1. US
          • 6.1.1.2. Canada
          • 6.1.1.3. Mexico
      • 6.2. Europe
        • 6.2.1. Europe Active Pharmaceutical Ingredient Market: Regional Trend Analysis
          • 6.2.1.1. Germany
          • 6.2.1.2. France
          • 6.2.1.3. UK
          • 6.2.1.4. Russia
          • 6.2.1.5. Italy
          • 6.2.1.6. Rest of Europe
      • 6.3. Asia-Pacific
        • 6.3.1. Asia-Pacific Active Pharmaceutical Ingredient Market: Regional Trend Analysis
          • 6.3.1.1. China
          • 6.3.1.2. Japan
          • 6.3.1.3. Korea
          • 6.3.1.4. India
          • 6.3.1.5. Rest of Asia
      • 6.4. Latin America
        • 6.4.1. Latin America Active Pharmaceutical Ingredient Market: Regional Trend Analysis
          • 6.4.1.1. Brazil
          • 6.4.1.2. Argentina
          • 6.4.1.3. Rest of Latin America
      • 6.5. Middle East and Africa
        • 6.5.1. Middle East and Africa Active Pharmaceutical Ingredient Market: Regional Trend Analysis
          • 6.5.1.1. GCC
          • 6.5.1.2. South Africa
          • 6.5.1.3. Israel
          • 6.5.1.4. Rest of MEA
    • 7. Global Active Pharmaceutical Ingredient Market Competitive Landscape, Market Share Analysis, and Company Profiles
      • 7.1. Market Share Analysis
      • 7.2. Company Profiles
      • 7.3. Teva
        • 7.3.1. Company Overview
        • 7.3.2. Financial Highlights
        • 7.3.3. Product Portfolio
        • 7.3.4. SWOT Analysis
        • 7.3.5. Key Strategies and Developments
      • 7.4. Novartis
        • 7.4.1. Company Overview
        • 7.4.2. Financial Highlights
        • 7.4.3. Product Portfolio
        • 7.4.4. SWOT Analysis
        • 7.4.5. Key Strategies and Developments
      • 7.5. Pfizer
        • 7.5.1. Company Overview
        • 7.5.2. Financial Highlights
        • 7.5.3. Product Portfolio
        • 7.5.4. SWOT Analysis
        • 7.5.5. Key Strategies and Developments
      • 7.6. Johnson & Johnson
        • 7.6.1. Company Overview
        • 7.6.2. Financial Highlights
        • 7.6.3. Product Portfolio
        • 7.6.4. SWOT Analysis
        • 7.6.5. Key Strategies and Developments
      • 7.7. Mylan
        • 7.7.1. Company Overview
        • 7.7.2. Financial Highlights
        • 7.7.3. Product Portfolio
        • 7.7.4. SWOT Analysis
        • 7.7.5. Key Strategies and Developments
      • 7.8. North China Pharmaceutical Group
        • 7.8.1. Company Overview
        • 7.8.2. Financial Highlights
        • 7.8.3. Product Portfolio
        • 7.8.4. SWOT Analysis
        • 7.8.5. Key Strategies and Developments
      • 7.9. Dr.Reddys Laboratories
        • 7.9.1. Company Overview
        • 7.9.2. Financial Highlights
        • 7.9.3. Product Portfolio
        • 7.9.4. SWOT Analysis
        • 7.9.5. Key Strategies and Developments
      • 7.10. Roche
        • 7.10.1. Company Overview
        • 7.10.2. Financial Highlights
        • 7.10.3. Product Portfolio
        • 7.10.4. SWOT Analysis
        • 7.10.5. Key Strategies and Developments
      • 7.11. Aurobindo pharma
        • 7.11.1. Company Overview
        • 7.11.2. Financial Highlights
        • 7.11.3. Product Portfolio
        • 7.11.4. SWOT Analysis
        • 7.11.5. Key Strategies and Developments
      • 7.12. Sun Pharmaceutical Industries
        • 7.12.1. Company Overview
        • 7.12.2. Financial Highlights
        • 7.12.3. Product Portfolio
        • 7.12.4. SWOT Analysis
        • 7.12.5. Key Strategies and Developments
      • 7.13. Boehringer Ingelheim GmbH
        • 7.13.1. Company Overview
        • 7.13.2. Financial Highlights
        • 7.13.3. Product Portfolio
        • 7.13.4. SWOT Analysis
        • 7.13.5. Key Strategies and Developments
      • 7.14. Bayer
        • 7.14.1. Company Overview
        • 7.14.2. Financial Highlights
        • 7.14.3. Product Portfolio
        • 7.14.4. SWOT Analysis
        • 7.14.5. Key Strategies and Developments
      • 7.15. BASF
        • 7.15.1. Company Overview
        • 7.15.2. Financial Highlights
        • 7.15.3. Product Portfolio
        • 7.15.4. SWOT Analysis
        • 7.15.5. Key Strategies and Developments
      • 7.16. DSM
        • 7.16.1. Company Overview
        • 7.16.2. Financial Highlights
        • 7.16.3. Product Portfolio
        • 7.16.4. SWOT Analysis
        • 7.16.5. Key Strategies and Developments
      • 7.17. Zhejiang Medicine
        • 7.17.1. Company Overview
        • 7.17.2. Financial Highlights
        • 7.17.3. Product Portfolio
        • 7.17.4. SWOT Analysis
        • 7.17.5. Key Strategies and Developments
      • 7.18. Biocon
        • 7.18.1. Company Overview
        • 7.18.2. Financial Highlights
        • 7.18.3. Product Portfolio
        • 7.18.4. SWOT Analysis
        • 7.18.5. Key Strategies and Developments
      • 7.19. Johnson Matthey
        • 7.19.1. Company Overview
        • 7.19.2. Financial Highlights
        • 7.19.3. Product Portfolio
        • 7.19.4. SWOT Analysis
        • 7.19.5. Key Strategies and Developments
      • 7.20. Hisun Pharmacy
        • 7.20.1. Company Overview
        • 7.20.2. Financial Highlights
        • 7.20.3. Product Portfolio
        • 7.20.4. SWOT Analysis
        • 7.20.5. Key Strategies and Developments
      • 7.21. Cambrex
        • 7.21.1. Company Overview
        • 7.21.2. Financial Highlights
        • 7.21.3. Product Portfolio
        • 7.21.4. SWOT Analysis
        • 7.21.5. Key Strategies and Developments
      • 7.22. Shandong Xinhua Pharmaceutical
        • 7.22.1. Company Overview
        • 7.22.2. Financial Highlights
        • 7.22.3. Product Portfolio
        • 7.22.4. SWOT Analysis
        • 7.22.5. Key Strategies and Developments
    • 8. Assumptions and Acronyms
    • 9. Research Methodology
    • 10. Contact
  • ondemand_videoVideos
    • 22857
    • Dec 2018
    • $2,495.00
    • $3,795.00
    • $4,995.00
    Buy Now
    • Teva
    • Novartis
    • Pfizer
    • Johnson & Johnson
    • Mylan
    • North China Pharmaceutical Group
    • Dr. Reddys Laboratories
    • Roche
    • Aurobindo pharma
    • Sun Pharmaceutical Industries
    • Boehringer Ingelheim GmbH
    • Bayer
    • BASF
    • DSM
    • Zhejiang Medicine
    • Biocon
    • Johnson Matthey
    • Hisun Pharmacy
    • Cambrex
    • Shandong Xinhua Pharmaceutical
  • settingsSettings

Related Reports

Animal Genetics Market Global Animal Genetics Market By Type (Animal Genetics Products, and Animal Genetics Testing Services), By Application (Poultry, Porcine, and Bovine), By Region and Key Companies - Industry Segment Ou...
Population Health Management Market Global Population Health Management Market By Type (Mobile population health management, and Remote population health monitoring), By Application (Hospital, Community health service institution, and N...
Behavioral Health Software Market Global Behavioral Health Software Market By Type (Ownership Model, and Subscription Model), By Application (Hospitals, Clinics, and Residential), By Region and Key Companies - Industry Segment Outlook...

Our Clients

Subscribe

Subscribe Now

Request for Sample

  • 22857
  • Dec 2018
  • $2,495.00
  • $3,795.00
  • $4,995.00
Buy Now

Find Help

Legal

Explore

Secured Payment Options

PayPal Payment System
Payoneer Payment System